Related references
Note: Only part of the references are listed.Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
Fernando Perez-Ruiz et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patients
S. Kopprasch et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
Davide Grassi et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Sushma Rekhraj et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Preservation of Renal Function During Gout Treatment With Febuxostat: A Quantitative Study
Andrew Whelton et al.
POSTGRADUATE MEDICINE (2013)
Risk of myocardial infarction among patients with gout: a nationwide population-based study
Chang-Fu Kuo et al.
RHEUMATOLOGY (2013)
Gout and its comorbidities: implications for therapy
Lisa K. Stamp et al.
RHEUMATOLOGY (2013)
Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010
Stephen P. Juraschek et al.
ARTHRITIS CARE & RESEARCH (2013)
Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
Augusto C. Montezano et al.
ANNALS OF MEDICINE (2012)
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature?: A critical appraisal
Tuhina Neogi et al.
ARTHRITIS AND RHEUMATISM (2012)
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
Puja P. Khanna et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Targeting NADPH oxidases in vascular pharmacology
Agata Schramm et al.
VASCULAR PHARMACOLOGY (2012)
Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia
A. -K. Tausche et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Association Between Gout and All-Cause as well as Cardiovascular Mortality: A Systematic Review
Kathrin Lottmann et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide
Nicola Dalbeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
Umair Z. Malik et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus
Hiroyuki Ito et al.
PLOS ONE (2011)
Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout
Puja P. Khanna et al.
RHEUMATOLOGY (2011)
Epidemiology of gout: An update
E. U. R. Smith et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
International position paper on febuxostat
Tim L. Jansen et al.
CLINICAL RHEUMATOLOGY (2010)
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'
Francesco U. S. Mattace-Raso et al.
EUROPEAN HEART JOURNAL (2010)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
Awsan Noman et al.
LANCET (2010)
Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study
Chang-Fu Kuo et al.
RHEUMATOLOGY (2010)
Mechanisms of inflammation in gout
Nathalie Busso et al.
ARTHRITIS RESEARCH & THERAPY (2010)
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Jacob George
Therapeutics and Clinical Risk Management (2010)
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
Jacob George et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2009)
Hyperuricemia, gout and the metabolic syndrome
Juan Garcia Puig et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium
Carsten Wunderlich et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
L. Annemans et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Uric acid and oxidative stress: Relative impact on cardiovascular risk
Pasquale Strazzullo et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
EULAR evidence based recommendations for gout.: Part I:: Diagnosis.: Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease
Daniel E. Weiner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Metabolic syndrome and age-related progression of aortic stiffness
ME Safar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Normal vascular aging: Differential effects on wave reflection and aortic pulse wave velocity - The Anglo-Cardiff Collaborative Trial (ACCT)
CM McEniery et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
